Lung Cancer Management

The Chinese Journal of Lung Cancer mainly reports on the new progress and achievements in basic research, clinical prevention and treatment, epidemiology and etiology, biology, pathology, clinical evaluation, surgical treatment, chemotherapy, radiation therapy, and multidisciplinary comprehensive treatment in the field of lung cancer. The magazine also timely tracks and reports on academic trends, research reports, and treatment experiences in the field of lung cancer at home and abroad, promoting academic exchanges and cooperation between the lung cancer community at home and abroad.

The magazine has multiple columns, including articles, reviews, commentaries, lectures, clinical experiences, case reports, new technologies, new theories, short reports, as well as continuing education and various news, with comprehensive and in-depth content. Its readership is broad, including medical personnel and researchers engaged in basic and clinical research on lung cancer, as well as clinical doctors, medical students, interns, graduate students, and pharmaceutical management personnel in related fields.

《中国肺癌杂志》主要报道肺癌领域的基础研究、临床防治、流行病学与病因学、生物学、病理学、临床评估、手术治疗、化疗、放射治疗以及多学科综合治疗等方面的新进展和新成果。杂志还及时追踪并报道国内外肺癌领域的学术动态、研究报告和治疗经验，促进了国内外肺癌界之间的学术交流与合作。

该杂志设有多个栏目，包括论著、综述、述评、讲座、临床经验、病例报告、新技术、新理论、短篇报道以及继续教育和各类消息等，内容全面且深入。其读者对象广泛，包括从事肺癌基础与临床研究的医务人员、研究人员，以及相关专业的临床医生、医学生、实习生、研究生和医药管理人员。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映RESPIRATORY SYSTEM领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为0.9，平均审稿速度为 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。